Repositioning Candidate Details
| Candidate ID: | R0224 |
| Source ID: | DB00784 |
| Source Type: | approved |
| Compound Type: | small molecule |
| Compound Name: | Mefenamic acid |
| Synonyms: | |
| Molecular Formula: | C15H15NO2 |
| SMILES: | CC1=C(C)C(NC2=CC=CC=C2C(O)=O)=CC=C1 |
| Structure: |
|
| DrugBank Description: | A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase. |
| CAS Number: | 61-68-7 |
| Molecular Weight: | 241.2851 |
| DrugBank Indication: | For the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhea, and mild to moderate pain, inflammation, and fever. |
| DrugBank Pharmacology: | Mefenamic acid, an anthranilic acid derivative, is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs). It exhibits anti-inflammatory, analgesic, and antipyretic activities. Similar to other NSAIDs, mefenamic acid inhibits prostaglandin synthetase. |
| DrugBank MoA: | Mefenamic acid binds the prostaglandin synthetase receptors COX-1 and COX-2, inhibiting the action of prostaglandin synthetase. As these receptors have a role as a major mediator of inflammation and/or a role for prostanoid signaling in activity-dependent plasticity, the symptoms of pain are temporarily reduced. |
| Targets: | Prostaglandin G/H synthase 2; Prostaglandin G/H synthase 1 |
| Inclusion Criteria: |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class |
|---|